Our ambition of building a multi-centric, pan-Indian T1D registry is being realised through the strength of strategic partnerships. Hinduja Foundation has teamed up with some of the leading diabetologists of the country to make the greatest impact among patients and access critical data on the condition. Our partners are committed to maintaining an exchange of best practices and ideas towards developing capacity at each of the centres. Data will be collected in a common proforma/data template and all samples will be bio-banked to support ongoing research.
Meet the principal investigators at the three centres that partner with us for the T1D Program.
Madras Diabetes Research Foundation (MDRF) is widely recognized as an eminent center for diabetes treatment and research in South Asia with a long history of successful cohort tracking, international collaborations and peer-reviewed research in diabetes. MDRF and Dr Mohan's Diabetes Specialities Centre are headed by Padma Shri Dr V Mohan, a world-renowned diabetologist.
The Diabetes Centre at the KEM Hospital in Pune is led by Director, Dr Chittaranjan Yajnik. Dr Yajnik is a world-renowned clinician and researcher and respected in the field of diabetes, especially for his research on the ‘Thin-Fat Indian’ and the neonatal origins of adult onset non-communicable diseases.
P. D. Hinduja Hospital & Medical Research Centre is an ultramodern tertiary care hospital in Mumbai offering world-class healthcare treatments and services. The hospital has a state-of-the-art centre for all endocrine problems, led by three consultants: Dr P. H. Chauhan [Head of Section and principal investigator], Dr N. F. Shah and Dr Manoj Chaddha. Through this project, the centre is further strengthening the capacity towards T1D care in Mumbai.
Through our collaborative research with our partners, we aim to support ground-breaking India-centric studies on juvenile diabetes.
"Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: Evidence from a study in India", co-authored by Dr Chittaranjan S. Yajnik, Director of the Diabetes Centre at KEM Hospital, Pune.
Click to downloadFindings from Dr Yajnik's paper were written up in Marathi for the Indian Diabetic Association's magazine Madhumitra.
Click to downloadOver the last year, we have successfully enrolled 650+ patients into the program and made a significant impact on their lives. An important indicator of progress is reduction in HbA1C, which is in turn a measure of blood glucose levels over the previous three months. It is well established that even a 1% reduction in HbA1C significantly reduces mortality and complications.
A glance at the progress charted at our partner centres.